Skip To Main Content
Ford Holland on Muck Rack

Ford Holland

As seen in: The Lancet

Get in touch with Ford

Contact Ford, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study

|
By Behfar Ehdaie, Clare Tempany, Ford Holland, Daniel D. Sjoberg
| The Lancet Verified
Men with grade group 2 or 3 prostate cancer are often considered ineligible for active surveillance; some patients with grade group 2 prostate cancer who are managed with active surveillance will have early disease progression requiring radical therapy. This study aimed to investigate whether MRI-guided focused ultrasound focal therapy can safely reduce treatment burden for patients with localised grade group 2 or 3 intermediate-risk prostate cancer.
Open in Who Shared Issue with article?
See all 1 articles